News EPFL

EPFL launches new classes in management and finance

Published:19.05.20 — Starting in September 2020, Bachelor’s students will have the option to take new classes in management and finance. Offered by the College of Management of Technology (CDM), these classes are designed to equip future engineering graduates with broad, versatile skillsets.

A deeper connection to hyaline fibromatosis syndrome

Published:18.05.20 — EPFL scientists have uncovered the molecular biology behind Hyaline Fibromatosis Syndrome, a severe genetic disease.

Designing vaccines from artificial proteins

Published:15.05.20 — EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines. This approach opens the possibility to engineer safer and more effective vaccines.

Appointment of EPFL professors

Published:14.05.20 — The Board of the Swiss Federal Institutes of Technology has announced the appointment of five professors at EPFL.

Speeding up long-range coherent LiDAR

Published:13.05.20 — LiDAR is a technique used for measuring distances with laser light. In a study published in Nature, researchers at EPFL show a new way to speed up a type of LiDAR engine by using photonic circuits.

Transistor sets a new standard for energy efficiency

Published:12.05.20 — Researchers at EPFL’s Nanoelectronic Devices Laboratory (Nanolab), working under Professor Adrian Ionescu, have designed and demonstrated a new type of technology based on 2D semiconducting materials that’s almost as energy-efficient as the human brain.

Peptides that can be taken as a pill

Published:11.05.20 — Peptides represent a billion-dollar market in the pharmaceutical industry, but they can generally only be taken as injections to avoid degradation by stomach enzymes. Scientists at EPFL have now developed a method to generate peptides that resist enzymatic degradation and can be taken orally.